Research Article
Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
Table 2
The determination of the best cutoff for tumor-stroma ratio (TSR) in EOC.
| TSR | Number | 3-year PFS | | P | 5-year survival rate | | P |
| <20% | 6 | 0 | 0.671 | 0.413 | 0 | 0.289 | 0.591 | ≥20% | 832 | 48.2% | 40% |
| <30% | 91 | 52.5% | 3.240 | 0.072 | 47.2% | 4.312 | 0.038 | ≥30% | 747 | 47.6% | 38.1% |
| <40% | 221 | 58.7% | 2.402 | 0.087 | 48.4% | 5.605 | 0.018 | ≥40% | 617 | 54.2% | 37.1% |
| <50% | 575 | 55.3% | 13.704 | <0.001 | 45.6% | 12.251 | <0.001 | ≥50% | 263 | 33.8% | 29.1% |
| <60% | 665 | 46.5% | 3.965 | 0.046 | 46.6% | 7.338 | 0.007 | ≥60% | 173 | 42.2% | 34.4% |
| <70% | 717 | 47.8% | 3.058 | 0.080 | 40.2% | 3.778 | 0.052 | ≥70% | 125 | 52.8% | 41.4% |
| <80% | 796 | 47.5% | 0.399 | 0.528 | 39.8% | 1.611 | 0.204 | ≥80% | 42 | 69% | 53.2% |
| <90% | 824 | 48.4% | 0.103 | 0.749 | 40.3% | 0.992 | 0.319 | ≥90% | 14 | 57.1% | 47.6% |
|
|
PFS: progression-free survival. Analysis was performed using the Kaplan-Meier method. The minimum value was indicated in bold font.
|